“A comparative, cross-over, double blind, randomized study for bioequivalence assessment between two formulations of valsartan capsules vs. tablets”., Colomb Med, vol. 37, no. 2, pp. 107–120, Jun. 2006, doi: 10.25100/cm.v37i2.421.